Anionic salivary proteins associated with connective tissue disorders: sialated tissue kallikreins. 1989

D Greaves, and J T Whicher, and K D Bhoola, and C Scully, and S Flint, and S R Porter, and R E Chambers, and P A Maddison, and J A Beeley, and R Matthews
Department of Oral Medicine, University of Bristol, UK.

Parotid saliva was collected from 32 patients with rheumatoid arthritis, 10 with systemic lupus erythematosus, three with mixed connective tissue disease, 12 with progressive systemic sclerosis, two with primary Sjögren's syndrome, and four with Raynaud's syndrome. Tissue kallikreins were measured by radioimmunoassay, and saliva samples were subjected to isoelectric focusing followed by immunoblotting or silver staining. The results showed that the saliva of patients with connective tissue diseases contained increased amounts of immunoreactive tissue kallikrein. In addition, there was an increase in the multiple forms of anionic tissue kallikreins, resulting mainly from a shift in their distribution towards that of higher sialic acid content and lower isoelectric point. These changes were most obvious in patients with systemic lupus erythematosus. Novel or unusual glycosylation may explain the occurrence of increased amounts of anionic salivary proteins in connective tissue diseases.

UI MeSH Term Description Entries
D007525 Isoelectric Focusing Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrofocusing,Focusing, Isoelectric
D007610 Kallikreins Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77). Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003240 Connective Tissue Diseases A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides. Connective Tissue Disease,Disease, Connective Tissue,Diseases, Connective Tissue
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D Greaves, and J T Whicher, and K D Bhoola, and C Scully, and S Flint, and S R Porter, and R E Chambers, and P A Maddison, and J A Beeley, and R Matthews
November 1995, Rheumatic diseases clinics of North America,
D Greaves, and J T Whicher, and K D Bhoola, and C Scully, and S Flint, and S R Porter, and R E Chambers, and P A Maddison, and J A Beeley, and R Matthews
August 2006, Current rheumatology reports,
D Greaves, and J T Whicher, and K D Bhoola, and C Scully, and S Flint, and S R Porter, and R E Chambers, and P A Maddison, and J A Beeley, and R Matthews
August 1992, Annals of the rheumatic diseases,
D Greaves, and J T Whicher, and K D Bhoola, and C Scully, and S Flint, and S R Porter, and R E Chambers, and P A Maddison, and J A Beeley, and R Matthews
March 1997, American journal of medical genetics,
D Greaves, and J T Whicher, and K D Bhoola, and C Scully, and S Flint, and S R Porter, and R E Chambers, and P A Maddison, and J A Beeley, and R Matthews
October 2014, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia,
D Greaves, and J T Whicher, and K D Bhoola, and C Scully, and S Flint, and S R Porter, and R E Chambers, and P A Maddison, and J A Beeley, and R Matthews
October 2016, Joint bone spine,
D Greaves, and J T Whicher, and K D Bhoola, and C Scully, and S Flint, and S R Porter, and R E Chambers, and P A Maddison, and J A Beeley, and R Matthews
February 2013, The Practitioner,
D Greaves, and J T Whicher, and K D Bhoola, and C Scully, and S Flint, and S R Porter, and R E Chambers, and P A Maddison, and J A Beeley, and R Matthews
April 2007, Dermatology nursing,
D Greaves, and J T Whicher, and K D Bhoola, and C Scully, and S Flint, and S R Porter, and R E Chambers, and P A Maddison, and J A Beeley, and R Matthews
June 1971, Kardiologiia,
D Greaves, and J T Whicher, and K D Bhoola, and C Scully, and S Flint, and S R Porter, and R E Chambers, and P A Maddison, and J A Beeley, and R Matthews
June 1978, ZFA. Zeitschrift fur Allgemeinmedizin,
Copied contents to your clipboard!